Healthcare Technology Executive Appointment

BioVigil Appoints Brad Ryba as CTO to Accelerate Innovation and Market Expansion

TM
Techmediaglobal
| 4 min read
25+
YEARS OF TECH LEADERSHIP
46.95%
AVG HAI REDUCTION
94%
AVG REAL COMPLIANCE RATE
100+
OBSERVATIONS/BED/DAY

BioVigil, the market leader in electronic hand hygiene and infection prevention technology, has named Brad Ryba as its new Chief Technology Officer (CTO). Ryba brings more than 25 years of technology leadership to the role, with deep expertise spanning SaaS, healthcare technology, insurance, telecommunications, and e-commerce. His appointment signals BioVigil's accelerating push to expand platform interoperability, deepen data capabilities, and advance its mission of making hospitals safer through automated hand hygiene excellence.

A Technology Leader Built for Healthcare's Next Chapter

Brad Ryba steps into the CTO role with a career defined by driving software quality, process redesign, and cross-functional execution at scale. He has partnered with Fortune 500 organizations to implement strategic technology initiatives and build robust data platforms — experience that directly maps to BioVigil's ambitions for deeper interoperability and expanded clinical integration.

In his new role, Ryba will lead BioVigil's technology and data strategy, with a mandate to drive greater integration across the BioVigil platform and advance its ability to blend seamlessly into existing hospital workflows. His cross-industry background — spanning healthcare technology, SaaS, and enterprise data platforms — positions him well to tackle the growing complexity of clinical environments demanding intelligent, connected solutions.

"With the healthcare market rapidly evolving, smart hospitals of the future are demanding intelligent, integrated solutions that enhance clinical workflows and elevate patient safety. Brad's deep experience in device design and data scale expertise is an ideal fit for our mission."

— Erik Axter, CEO, BioVigil

What Makes BioVigil's Platform Unique

BioVigil is the only automated solution on the market that provides individual hand hygiene verification with real-time compliance correction. At the core of the platform is a smart wearable badge equipped with a patented alcohol vapor sensor — the only such device available today — that physically confirms when hand sanitizer has been applied, rather than relying on proximity or self-reporting.

The system pairs the badge with room beacons and sink sensors, delivering over 100 hand hygiene observations per bed per day — far exceeding what traditional direct observation methods can capture. Real-time visual, audible, and vibratory cues on the badge prompt immediate course correction, while a visible green compliance indicator builds patient trust at the point of care. Critically, the solution requires no changes to existing hospital IT infrastructure and is sanitizer-product agnostic.

Proven Results: The Case for Automated Hand Hygiene

The clinical impact of BioVigil's platform is well-documented. Aggregated performance data across partner facilities shows an average HAI reduction of 46.95%, sustained year over year. In a single year, the platform captured more than 67.6 million hand hygiene opportunities and corrected over 1.1 million non-compliant events at the point of care — eliminating the sampling bias inherent in manual observation models.

BioVigil partners maintain an average real compliance rate of 94%, and the platform frequently pays for itself through HAI-related cost avoidance. Founded in 2012 and headquartered in Ann Arbor, Michigan, BioVigil is trusted by hospitals nationwide — from large multi-state health systems to community hospitals — making Ryba's appointment a timely move as the company eyes broader market expansion.

Strategic Priorities Under Ryba's Leadership

Ryba's mandate centers on three interconnected priorities: advancing platform interoperability so BioVigil integrates more fluidly with existing clinical workflows and health system infrastructure; scaling the company's data capabilities to deliver richer insights around compliance performance, staff rounding, and contact tracing; and accelerating the development of next-generation product offerings that meet the demands of smart hospitals.

The appointment follows BioVigil's recent hiring of Jason Tercek as Chief Operating Officer, signalling a sustained build-out of the company's senior leadership team in support of national growth. With Ryba now heading technology and data strategy, BioVigil is positioning itself to move from a proven clinical solution to a fully integrated, data-driven platform capable of supporting enterprise-wide infection prevention programs across the healthcare system.

Key Takeaways

  • BioVigil has appointed Brad Ryba as CTO to lead technology and data strategy, driving greater interoperability and integration across its hand hygiene platform.
  • Ryba brings over 25 years of technology leadership spanning SaaS, healthcare technology, insurance, telecommunications, and e-commerce, including work with Fortune 500 organizations.
  • BioVigil is the only automated solution offering individual hand hygiene verification via a patented alcohol vapor-sensing smart badge — requiring no changes to existing hospital infrastructure.
  • Partner facilities have achieved an average HAI reduction of 46.95% and a real compliance rate of 94%, with over 67.6 million hand hygiene opportunities captured in a single year.
  • Ryba's appointment follows the recent hire of a Chief Operating Officer, reflecting a deliberate expansion of BioVigil's senior leadership team to support national market growth.
  • BioVigil's strategic focus under Ryba will centre on platform interoperability, advanced data capabilities, and next-generation product development for the smart hospital of the future.
Tags: BioVigil Brad Ryba Healthcare Technology Infection Prevention Hand Hygiene CTO Appointment Patient Safety